(Q43988206)

28 November 2017

Immunomodulatory therapy for pediatric inflammatory bowel disease: changing patterns of use, 1990-2000. (English)

1 reference

inflammatory bowel diseases

28 November 2017

0 references

inflammation

0 references

author name string

James Markowitz

1

1 reference

28 November 2017

Kathy Grancher

2

1 reference

28 November 2017

Nina Kohn

3

1 reference

28 November 2017

Fredric Daum

4

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

The American Journal of Gastroenterology

28 November 2017

1 reference

28 November 2017

97

1 reference

28 November 2017

4

1 reference

28 November 2017

928-932

1 reference

6-Mercaptopurine Therapy in Selected Cases of Corticosteroid-Dependent Crohn's Disease

28 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05611.X

Quality of life in children with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05611.X

Controlled trial of azathioprine in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05611.X

Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05611.X

Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05611.X

Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05611.X

Tacrolimus (FK-506) treatment of fulminant colitis in a child

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05611.X

Experiences with 6-mercaptopurine and azathioprine therapy in pediatric patients with severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05611.X

6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05611.X

Controlled trial of azathioprine in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05611.X

Introduction of 6-mercaptopurine in Crohn's disease patients during the perioperative period: a preliminary evaluation of recurrence of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05611.X

Azathioprine and 6-mercaptopurine for the treatment of perianal Crohn's disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05611.X

Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05611.X

10.1111/J.1572-0241.2002.05611.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference